Market Research Report
Eye Infections Treatment Market: By Category (Conjunctivitis, Blepharitis, Keratitis, Others); By Cause of Infection (Bacteria, Viruses, Irritants, Allergies); By Drug Type (Corticosteroids, Others) & By Region (Europe, Others) -Forecast 2019-2024
|Published by||IndustryARC||Product code||421918|
Delivery time: 2-3 business days
|Eye Infections Treatment Market: By Category (Conjunctivitis, Blepharitis, Keratitis, Others); By Cause of Infection (Bacteria, Viruses, Irritants, Allergies); By Drug Type (Corticosteroids, Others) & By Region (Europe, Others) -Forecast 2019-2024|
|Published: December 27, 2018||Content info:||
Eye Infections are caused due to various viruses, bacteria, parasites, and fungi that can invade the human body. It is more frequent in Afro-Caribbean's, Arabs, and Asian countries having warmer climate. Globally, availability of new and more efficient drugs such as eye drop or eye ointment, change in population demographics, and increasing frequency of blindness amongst the geriatric population are the prime growth drivers of global eye infections treatment market. In addition, increase in adoption of eye infections treatment drugs in emerging economies such as China, India and others owing to growing health awareness and government initiatives, and countries with warm climatic conditions will create new opportunities for global eye infections treatment market. However, higher cost of the research and development, and testing, and stringent government regulations are the key restraints for global eye infections treatment market.
This report identifies the global eye infections treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global eye infections treatment market.
Geographically Asia dominated global eye infections treatment market, and is projected to have fastest growth, owing to rapidly increasing aging population, warm climatic condition and modernizing healthcare infrastructure in this region. Among all the category of eye infection, conjunctivitis has the highest market share in global eye infections treatment market.
Eye Infections Treatment Market, By Category: Conjunctivitis, Blepharitis, Keratitis, Vitritis, Chorioretinitis and Neuroretinitis
Eye Infections Treatment Market, By Cause of Infection: Bacteria, Viruses, Irritants and Allergies
Eye Infections Treatment Market, By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotic / Polypeptide Antibiotic / Corticosteroid Combinations, Aminoglycoside Antibiotics, Sulfa Antibiotics and Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region
Roche Holding AG
GlaxoSmithKline Pharmaceuticals Ltd
Valeant Pharmaceuticals International, Inc.
Novartis International AG
Santen Pharmaceutical Co., Ltd.
More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"